Literature DB >> 1751271

Clearance of atracurium and laudanosine in the urine and by continuous venovenous haemofiltration.

E S Shearer1, E P O'Sullivan, J M Hunter.   

Abstract

We have measured the steady state urinary clearances of atracurium, given by constant infusion, and laudanosine in eight patients undergoing artificial ventilation; all had normal renal function (mean creatinine clearance 81 ml min-1). Mean (SD) urinary clearance of atracurium was 0.55 (0.5) ml kg-1 min-1; that of laudanosine was 0.33 (0.2) ml kg-1 min-1. Simultaneous plasma clearances were 7.1 (1.4) ml kg-1 min-1 and 3.8 (1.5) ml kg-1 min-1, respectively. Notional haemofiltration clearances of the two substances were measured also in seven critically ill patients with renal and respiratory failure undergoing continuous venovenous haemofiltration. Mean (SD) clearances of atracurium and laudanosine in the haemofiltrate fluid were 0.11 (0.06) ml kg-1 min-1 and 0.09 (0.02) ml kg-1 min-1, respectively whilst plasma clearances were atracurium 6.7 (1.8) ml kg-1 min-1 and laudanosine 4.5 (1.8) ml kg-1 min-1. There were no significant differences between the plasma clearances of the drugs in the two groups, despite the difference in severity of sickness. Urinary clearance rates of atracurium and laudanosine were approximately 8 and 9% of that in the plasma, but the haemofiltration clearance of both substances was only 2%.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1751271     DOI: 10.1093/bja/67.5.569

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

Review 1.  Atracurium and laudanosine pharmacokinetics in acute renal failure.

Authors:  J M Hunter
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

2.  Atracurium infusions in patients with fulminant hepatic failure awaiting liver transplantation.

Authors:  J F Bion; M I Bowden; B Chow; L Honisberger; B C Weatherley
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 3.  The use of muscle relaxants in the intensive care unit.

Authors:  M D Sharpe
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.